Welcome to
NOK Therapeutics
We are a clinical-stage biotechnology company pioneering a new paradigm in cancer care: safe, practical, and timely natural killer (NK) cell therapies.
Welcome to
NOK Therpeutics
We are a clinical-stage biotechnology company pioneering a new paradigm in cancer care: safe, practical, and timely natural killer (NK) cell therapies. v
Our Mission &
Vision for the Future
Our mission is simple yet ambitious: to restore the body’s first line of immune defense at the moments when patients need it most.
Vision: To normalize this new category of immunotherapy – cell therapies designed for the precise therapeutic moments when cures are within reach.
NOK's Approach
Filling the Critical Gap in Oncology
NOK Therapeutics was founded to fill a critical gap in oncology with autologous, non-engineered NK cell therapies designed to extend remission, expand access, and integrate seamlessly into standard cancer care.
Addressing Relapse
Our NK cells are designed for patients who relapse despite aggressive frontline therapy.
Expanding Access
Many are excluded from cell therapies due to toxicity, cost, or logistics – our NK cells fill this critical gap.
Seamless Integration
Our NK cell therapies are designed for practical use with outpatient infusions and flexible re-dosing highly feasible.
Led by Industry Veterans
Leadership with combined 50 years in pharmaceutical development and involvement in 45+ FDA approvals.
